Laura Fugazzola Selected Research

Neoplasms (Cancer)

5/2024	dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe.
11/2023	Improved guidance is needed to optimise diagnostics and treatment of patients with thyroid cancer in Europe.
11/2022	Oxidative Stress Correlates with More Aggressive Features in Thyroid Cancer.
1/2022	FAM83B is involved in thyroid cancer cell differentiation and migration.
1/2022	Unilateral Surgery for Medullary Thyroid Carcinoma: Seeking for Clinical Practice Guidelines.
1/2022	Thyroid cancer harboring PTEN and TP53 mutations: A peculiar molecular and clinical case report.
12/2021	Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4).
9/2021	Post-Surgical Ablative or Adjuvant Radioiodine Therapy Has No Impact on Outcome in 1-4 cm Differentiated Thyroid Cancers without Extrathyroidal Extension.
11/2020	Recent advances in the management of anaplastic thyroid cancer.
11/2019	Genetic variants of PARP4 gene and PARP4P2 pseudogene in patients with multiple primary tumors including thyroid cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laura Fugazzola Research Topics

Disease

26	Thyroid Neoplasms (Thyroid Cancer) 04/2024 - 07/2002
23	Neoplasms (Cancer) 05/2024 - 10/2005
11	Hypothyroidism 02/2021 - 04/2002
10	medullary Thyroid cancer 01/2023 - 06/2007
8	Papillary Thyroid Cancer 05/2024 - 10/2005
8	Congenital Hypothyroidism (Cretinism) 01/2019 - 08/2003
6	Thyroid Nodule (Nodule, Thyroid) 04/2024 - 01/2010
5	Thyroiditis 04/2024 - 05/2010
5	Lymphatic Metastasis 12/2021 - 10/2005
5	Goiter 01/2019 - 04/2002
5	Pendred syndrome 07/2011 - 01/2006
4	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2009
4	Sensorineural Hearing Loss 09/2007 - 04/2002
3	Carcinoma (Carcinomatosis) 05/2024 - 01/2016
3	Fatigue 04/2024 - 12/2015
3	Adenoma (Adenomas) 11/2021 - 01/2016
3	Hyperplasia 01/2016 - 06/2007
3	Deafness (Deaf Mutism) 04/2012 - 01/2006
2	COVID-19 08/2023 - 01/2022
2	Hypocalcemia 01/2023 - 12/2015
2	Hypertension (High Blood Pressure) 01/2023 - 12/2015
2	Thyroid Diseases (Thyroid Disease) 11/2022 - 01/2019
2	Follicular Adenocarcinoma 01/2022 - 10/2005
2	Nodular Goiter 11/2021 - 03/2012
2	Thyroid Dysgenesis (Thyroid Agenesis) 01/2021 - 09/2007
2	Graves Ophthalmopathy 01/2021 - 01/2021
2	Thyrotoxicosis 11/2019 - 09/2005
2	Multiple Endocrine Neoplasia Type 2a (MEN 2) 05/2015 - 08/2003
2	Hyperthyroidism 09/2005 - 02/2005
1	Anaplastic Thyroid Carcinoma 05/2024
1	Secondary Hyperparathyroidism 01/2023
1	Tumor Lysis Syndrome 01/2023
1	Heart Failure 11/2022
1	Hypercalcemia (Milk Alkali Syndrome) 10/2022
1	Hypoparathyroidism 10/2022
1	Genomic Instability 01/2022
1	Acute Cholecystitis 07/2021
1	Cytokine Release Syndrome 05/2021

Drug/Important Bio-Agent (IBA)

10	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2022 - 06/2007
8	lenvatinibIBA 01/2023 - 01/2019
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2006
7	Thyroxine (Levothyroxine)FDA LinkGeneric 11/2021 - 08/2003
6	CalciumIBA 01/2023 - 03/2012
5	Tyrosine Kinase InhibitorsIBA 10/2022 - 01/2019
5	Dual OxidasesIBA 01/2019 - 10/2005
4	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 04/2024 - 01/2014
4	DNA (Deoxyribonucleic Acid)IBA 08/2023 - 06/2010
4	IodineIBA 09/2021 - 09/2007
4	Thyroglobulin FDA Link 01/2021 - 07/2002
4	Thyrotropin Alfa FDA LinkGeneric 01/2018 - 08/2003
4	IodidesIBA 07/2011 - 10/2005
3	Hydrocortisone (Cortisol)FDA LinkGeneric 04/2024 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2018
3	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 09/2010
3	Thyroid HormonesIBA 01/2021 - 02/2005
3	Messenger RNA (mRNA)IBA 11/2019 - 07/2002
3	perchlorateIBA 09/2007 - 04/2002
2	Cortisone FDA Link 04/2024 - 01/2019
2	Amiodarone (Amiodarona)FDA LinkGeneric 11/2022 - 11/2019
2	RacivirIBA 01/2022 - 02/2017
2	EnzymesIBA 07/2021 - 10/2005
2	Rituximab (Mabthera)FDA Link 01/2021 - 01/2021
2	SteroidsIBA 01/2021 - 11/2019
2	Methylprednisolone FDA LinkGeneric 01/2021 - 11/2019
2	MicroRNAs (MicroRNA)IBA 11/2020 - 01/2018
2	Ethanol (Ethyl Alcohol)IBA 01/2019 - 11/2014
2	vandetanib (ZD6474)IBA 01/2019 - 01/2018
2	pyrazolanthroneIBA 02/2017 - 11/2015
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2016 - 01/2015
2	Estrogens (Estrogen)FDA Link 07/2015 - 01/2010
2	ChloridesIBA 07/2011 - 01/2006
2	L-SelectinIBA 05/2010 - 10/2005
1	Ligases (Synthetase)IBA 05/2024
1	Persistent Organic PollutantsIBA 04/2024
1	perfluoro-n-nonanoic acidIBA 04/2024
1	perfluorooctane sulfonic acidIBA 04/2024
1	Mitochondrial DNA (mtDNA)IBA 01/2024
1	selpercatinibIBA 01/2023
1	MagnesiumIBA 01/2023
1	Parathyroid Hormone (Parathormone)IBA 01/2023
1	tyramine-deoxysorbitolIBA 11/2022
1	Contrast MediaIBA 11/2022
1	prolinedithiocarbamate (PDTC)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Trace Elements (Biometals)IBA 01/2022
1	ZincIBA 01/2022
1	CopperIBA 01/2022
1	SeleniumIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 05/2021
1	Iodide Peroxidase (Deiodinase)IBA 05/2021
1	Estradiol (Delestrogen)FDA LinkGeneric 02/2021

Therapy/Procedure

20	Therapeutics 05/2024 - 08/2003
8	Thyroidectomy 01/2022 - 03/2009
2	Aftercare (After-Treatment) 01/2022 - 09/2005
1	Radiofrequency Ablation 04/2024
1	Retreatment 12/2023
1	Lymph Node Excision (Lymph Node Dissection) 01/2022
1	Conservative Treatment 07/2021
1	Neck Dissection (Radical Neck Dissection) 06/2021
1	Radiotherapy 06/2021